Extensive Genetic Diversity within the Dutch Clinical Cryptococcus neoformans Population

Resistance of Asian Cryptococcus neoformans Serotype A Is Confined to Few Microsatellite Genotypes

(2012) Weihua Pan et al.   PLoS One

In vitro antifungal susceptibilities and molecular typing of sequentially isolated clinical Cryptococcus neoformans strains from Croatia

(2011) E. Mlinaric-Missoni et al.   JOURNAL OF MEDICAL MICROBIOLOGY

In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India

(2011) A. Chowdhary et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Identification of Novel Hybrids Between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII

(2011) Mojgan Aminnejad et al.   MYCOPATHOLOGIA

In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus gattii Isolates

(2010) F. Hagen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease

(2010) Tran TH Chau et al.   BMC INFECTIOUS DISEASES

Microsatellite typing and susceptibilities of serial Cryptococcus neoformansisolates from Cuban patients with recurrent cryptococcal meningitis

(2010) María T Illnait-Zaragozí et al.   BMC INFECTIOUS DISEASES

Prevalence of the VNIc genotype of Cryptococcus neoformans  in non-HIV-associated cryptococcosis in the Republic of Korea

(2010) Young Hwa Choi et al.   FEMS YEAST RESEARCH

Most Cases of Cryptococcal Meningitis in HIV-Uninfected Patients in Vietnam Are Due to a Distinct Amplified Fragment Length Polymorphism-Defined Cluster of Cryptococcus neoformans var. grubii VN1

(2010) J. N. Day et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In-hospital mortality of HIV-infected cryptococcal meningitis patients withC. gattiiandC. neoformansinfection in Gaborone, Botswana

(2010) Katherine T. Steele et al.   MEDICAL MYCOLOGY

Activated dormantCryptococcus gattiiinfection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approach

(2010) Ferry Hagen et al.   MEDICAL MYCOLOGY

Antifungal susceptibility, serotyping, and genotyping of clinicalCryptococcus neoformansisolates collected during 18 years in a single institution in Madrid, Spain

(2010) Jesús Guinea et al.   MEDICAL MYCOLOGY

Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997–2007

(2010) Li-Ping Zhu et al.   MEDICAL MYCOLOGY

Microsatellite Typing of Clinical and Environmental Cryptococcus neoformans var. grubii Isolates from Cuba Shows Multiple Genetic Lineages

(2010) Maria-Teresa Illnait-Zaragozi et al.   PLoS One

Mixed Infections and In Vivo Evolution in the Human Fungal Pathogen Cryptococcus neoformans

(2010) M. Desnos-Ollivier et al.   mBio

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

(2009) Benjamin J Park et al.   AIDS

Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility

(2009) S-J. Liaw et al.   CLINICAL MICROBIOLOGY AND INFECTION

Consensus multi-locus sequence typing scheme forCryptococcus neoformansandCryptococcus gattii

(2009) Wieland Meyer et al.   MEDICAL MYCOLOGY

Genetic Diversity of the Cryptococcus Species Complex Suggests that Cryptococcus gattii Deserves to Have Varieties

(2009) Popchai Ngamskulrungroj et al.   PLoS One

Diversidad del complejo de especies Cryptococcus neoformans-Cryptococcus gattii

(2009) Marjan Bovers et al.   REVISTA IBEROAMERICANA DE MICOLOGIA

Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans

(2008) G. R. Thompson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of the New Azole Isavuconazole (BAL4815) Compared with Six Other Antifungal Agents against 162 Cryptococcus neoformans Isolates from Cuba

(2008) M.-T. Illnait-Zaragozi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Six monophyletic lineages identified within Cryptococcus neoformans and Cryptococcus gattii by multi-locus sequence typing

(2007) M. Bovers et al.   FUNGAL GENETICS AND BIOLOGY